These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9705197)
41. [Guidelines for introducing new drugs for medical use in Poland and control of their quality]. Danysz A Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321 [No Abstract] [Full Text] [Related]
42. Counterfeit drugs: implications for health. ten Ham M Adverse Drug React Toxicol Rev; 1992; 11(1):59-65. PubMed ID: 1606284 [No Abstract] [Full Text] [Related]
43. Spurious drugs. Mittal SB J Indian Med Assoc; 2000 Aug; 98(8):464. PubMed ID: 11294333 [No Abstract] [Full Text] [Related]
45. World agencies try to stem flood of fake drugs. Surendran A Nat Med; 2004 Feb; 10(2):111. PubMed ID: 14760401 [No Abstract] [Full Text] [Related]
46. Substandard and counterfeit antimicrobials: recent trends and implications to key public health interventions in developing countries. Tadeg H; Berhane Y East Afr J Public Health; 2012 Jun; 9(2):85-9. PubMed ID: 23139963 [TBL] [Abstract][Full Text] [Related]
50. Health ministry institutes reward scheme for whistle-blowers reporting spurious drugs. Bhan A Natl Med J India; 2010; 23(1):56. PubMed ID: 20839601 [No Abstract] [Full Text] [Related]
51. Drug recalls as viewed by the manufacturer. Mitchell CM J Am Pharm Assoc; 1967 Nov; 7(11):575-7. PubMed ID: 6063674 [No Abstract] [Full Text] [Related]
52. Quality assurance during the production process. Tucker JD Med Serv J Can; 1967 Mar; 23(3):262-9. PubMed ID: 6056371 [No Abstract] [Full Text] [Related]
53. A proposed European pharmacopeia monograph for continuous cell lines derived drugs. Dorpema JW Dev Biol Stand; 1989; 70():113-24. PubMed ID: 2759345 [No Abstract] [Full Text] [Related]
54. The INN crowd. Nat Biotechnol; 2013 Dec; 31(12):1055. PubMed ID: 24316620 [No Abstract] [Full Text] [Related]
55. [Counterfeit and fake drugs: medications that kill]. Ambroise-Thomas P Med Trop (Mars); 2010 Jun; 70(3):213-4. PubMed ID: 20734583 [No Abstract] [Full Text] [Related]
57. Tide turns for drug manufacturing in Africa. Anderson T Lancet; 2010 May; 375(9726):1597-8. PubMed ID: 20458781 [No Abstract] [Full Text] [Related]
58. [Official inspections of a pharmaceutical plant during the registration of new products]. De Martiis F; Fontani F; Zanotti-Gerosa A Boll Chim Farm; 1982 Jul; 121(7):319-27. PubMed ID: 7150440 [No Abstract] [Full Text] [Related]
59. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products. Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700 [No Abstract] [Full Text] [Related]